SEC Form 4 · accession 0000884731-16-000097
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Clackson
Officer — President, R&D, CSO
Period of report
Aug 12, 2016
Accepted (ET)
Aug 15, 2016 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 12, 2016 | M | 25,000 | $7.69 | A | 273,208 | D | |
| Common StockF2 | Aug 12, 2016 | S | 25,000 | $10.50 | D | 248,208 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $7.69 | Aug 12, 2016 | M | 25,000 | D | Mar 11, 2014 | Mar 11, 2024 | Common Stock | 25,000 | 0 | D |
Explanation of responses
- F1Shares were acquired from exercise of an outstanding stock option pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2015
- F2Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2015